Alchemi Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.18M Buy
1,820
+12
+0.7% +$12.3K 1.02% 23
2026
Q1
$1.66M Buy
1,808
+7
+0.4% +$7.1K 0.92% 23
2025
Q4
$1.94M Buy
+1,801
New +$1.72M 1.06% 19

Other funds holding LLY

Alchemi Wealth's LLY Position: Q2 2026 in Review

Alchemi Wealth increased its Eli Lilly (LLY) stake by 0.66% in Q2 2026, buying an estimated $12.3K and bringing the position to 1,820 shares worth $2.18M. The position accounts for 1.02% of the portfolio, ranked #23.

Alchemi Wealth first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,612 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Alchemi Wealth held 1,820 shares of Eli Lilly worth $2.18M as of Q2 2026.
  • Alchemi Wealth bought 12 Eli Lilly shares in Q2 2026, an estimated $12.3K.
  • Eli Lilly made up 1.02% of Alchemi Wealth's portfolio in Q2 2026, its #23 holding.
  • Alchemi Wealth first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,612 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Alchemi Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.